Introduction {#sec1-1}
============

A cataract is a clouding that develops in the crystalline lens of the eye or in its envelope; varying in degree from slight to complete opacity and obstructing the passage of light. According to the World Health Organization (WHO), cataract is the most common cause of blindness; accounting for 47.8% of the 161 million visually disabled people worldwide.\[[@ref1]\] Previously, many studies investigated the association between genetic polymorphism and senile cataract.\[[@ref2]\] Angiotensin-converting enzyme (*ACE*) is a key enzyme that converts inactive angiotensin I into a vasoactive and aldosterone-stimulating peptide angiotensin II. In some cases, the increase of *ACE* protein is responsible for the elevation of angiotensin II level.\[[@ref3]\] Previously, ACE Alu polymorphism has been associated with proliferative diabetic retinopathy.\[[@ref4]\] Most of the recognized renin-angiotensin system (RAS) components such as *ACE*, prorenin, renin, and angiotensinogen have already been detected in the human eye.\[[@ref5]\] In addition to circulatory RAS, there is a tissue-localized system, and local RAS may have a significant role in the formation of aqueous humor and also in its drainage.\[[@ref5]\] The *ACE* gene has been the main probable candidate gene predisposing the development of diabetic retinopathy. Findings of Movva *et al*. also demonstrated D allele carriers with type 2 diabetes to be more vulnerable to the development of diabetic nephropathy.\[[@ref6]\]

*CYP46A1* is a member of the cytochrome P-450 family. It converts cholesterol to 24S-hydroxycholesterol. A single-nucleotide polymorphism (SNP) in the *CYP46A1* gene, designated as rs754203 and associated with Alzheimer disease, was evaluated as a genetic risk factor for primary open-angle glaucoma (POAG) as well as plasma 24S-hydroxycholesterol levels.\[[@ref7]\] Cholesterol-24S-hydroxylase was initially identified as a cholesterol-metabolizing enzyme in the brain. Accumulating evidence suggests that cholesterol is a risk factor for Alzheimer\'s disease;\[[@ref8][@ref9][@ref10]\]*CYP46A1* has also been detected in rodent and bovine retinal ganglion cells, indicating a physiologic role in the cholesterol metabolism of the mammalian retina.\[[@ref11][@ref12]\] Human lens\' membranes contain the highest cholesterol content of any known biological membrane. Defects in enzymes of cholesterol metabolism and use of drugs which inhibit lens cholesterol biosynthesis can be associated with cataracts.\[[@ref13]\] The aim of the study was to investigate the association between *ACE* and *CYP46A1* genes polymorphism and senile cataract cases.

Materials and Methods {#sec1-2}
=====================

Patient selection {#sec2-1}
-----------------

The study enrolled 103 senile cataract cases from the Outpatient Department of Cataract Clinic Department of Ophthalmology at Era\'s Lucknow Medical College and Hospital, Lucknow. Clinical and biochemical parameters were also done for each patient. Data collection was done for each patient on clinical variables including age, alcohol consumption, body mass index, height, weight, cigarette smoking, and family history. All patients with senile cataract had visual disturbance and their corrected visual acuities were under 6/24. We excluded patients with secondary cataract due to diabetes, trauma, steroid administration, and other causes. One hundred and two healthy volunteers without age-related cataract or other age-related ocular diseases were enrolled as the control group in the same clinic. Informed consent was obtained from each patient before the study.

Ethical compliance {#sec2-2}
------------------

Protocol and procedures employed were reviewed and approved by the Institutional Ethical/Review Committee.

DNA extraction {#sec2-3}
--------------

Five milliliters of peripheral blood was collected from all the patients in 0.5 M EDTA tubes. Genomic DNA was isolated from whole blood using the standard phenol-chloroform extraction method.\[[@ref14]\] The DNA concentration was determined by spectrophotometer and stored at −20°C.

Analysis of polymorphisms {#sec2-4}
-------------------------

### Angiotensin-converting enzyme polymorphism {#sec3-1}

Polymerase chain reaction (PCR) was employed for genotyping of the *ACE* I/D polymorphism. Reactions were performed with 10 pmol of each primer: forward primer 5\'-CTGGAGACCACTCCCATCCTTTCT-3\', reverse primer 5\'-GATGTGGCCATCTTCGTCAGAT -3\', in a final volume of 20 μl containing 3 mM MgCl~2~, 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 0.5 mM of each dNTPs, and 2U Taq polymerase. PCR amplification was carried out under the conditions: Initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 45 s, annealing at 60°C for 1.15 min, extension at 72°C for 2.30 min, and final extension at 72°C for 5 min. PCR products were separated on 2.0% ethidium bromide-stained agarose gel and visualized by UVP BioImaging gel doc system. The product was 490 bp for allele I and 190 bp for allele D \[[Figure 1](#F1){ref-type="fig"}\].

![Agarose gel picture showing polymerase chain reaction product for angiotensin-.converting enzyme polymorphism. Lane 1, 2 and 8 is I/I genotype (490 bp), lane 6, 7 is I/D genotype, lane 3 and 5 is D/D genotype (190 bp), and lane 4 is 100 bp ladder](OJO-10-21-g001){#F1}

### *CYP46A1* polymorphism {#sec3-2}

Genotyping was performed using PCR-restriction fragment length polymorphism with the following primer: forward primer: 5\'-TGAAAACGAGTTTCCCGTCC- 3\'; reverse primer: 5\'-GTGTGACCAGGTAACAGTCA-3\' in a 12.5-μl volume reaction with 1.25 U of DNA polymerase, 1.5 mM of MgCl~2~, 1.25 μl of 10X NH4 buffer, 200 μM dNTPs (BIOTaq; Bioline GmbH, Luckenwalde, Germany). After initial denaturation at 95°C for 8 min, the reaction mixture was subjected to 50 cycles of 1-min denaturation at 95°C, 1-min annealing at 53°C, and a 2-min extension at 72°C, followed by a final extension at 72°C for 5 min. The PCR products were digested by MspI (Promega, Charbonnières, France). The fragment amplification and digestion results were revealed by 1.8% agarose gel electrophoresis and ethidium bromide staining. The *CYP46A1*\*T allele corresponded to the uncut 285-bp fragment, whereas the *CYP46A1*\*C allele was characterized by two fragments of 209 and 76 bp \[[Figure 2](#F2){ref-type="fig"}\].

![Agarose gel picture showing PCR-RFLP product for *CYP46A1* gene polymorphism. The *CYP46A1*\*T allele corresponds to uncut 285 bp fragment, whereas the *CYP46A1*\*C allele characterized by two fragment of 209 bp and 76 bp. Lane 3 shows C/T genotype, lane 6 shows C/C genotype, lane 1, 2, 5, and 7 shows T/T genotype, and lane 4 shows 100 bp ladder](OJO-10-21-g002){#F2}

Statistical analysis {#sec2-5}
--------------------

All the figures are presented as means ± standard deviation. The genotyping data were compared between cases and controls using Chi-square test. Other variables were compared using Student\'s *t*-test for normally distributed variables. Hardy--Weinberg (HW) equilibrium has been calculated using HW Diagnostics-Version 1 beta (Fox Chase Cancer Center, Philadelphia, PA, USA). All statistical tests were performed using Statistical Package for the Social Sciences version 12 software International Business Machines Corp, New Orchard Road, Armonk, New York.

Results {#sec1-3}
=======

Our study included 103 senile cataract cases (55 were males and 48 were females) and 102 controls (53 were males and 49 were females). Mean age of the cases in this study was 52.02 ± 12.11 years, while in control group, it was 53.74 ± 11.87 years. Clinical and biochemical parameters of cases and controls are shown in [Table 1](#T1){ref-type="table"}.

###### 

Clinical and biochemical parameters of cataract cases and controls

![](OJO-10-21-g003)

Hardy--Weinberg equilibrium test {#sec2-6}
--------------------------------

*ACE* and *CYP46A1* genotype distributions in all cases and controls were in line with HW equilibrium (all *P* \> 0.05, data not shown).

Genetic polymorphism analysis {#sec2-7}
-----------------------------

### Angiotensin-converting enzyme polymorphism analysis {#sec3-3}

*ACE* gene ID, DD, II genotype frequencies were 64.07%, 4.85%, 31.06% in cases and 61.76%, 26.47%, 11.76% in controls, respectively. Odds ratio (OR) for ID genotype was 1.104 (*P* = 0.732), for DD genotype OR = 0.142 (*P* \< 0.001), for II genotype OR was 3.38 (*P* = 0.0008). The frequency of I and D allele in cases was 63.11% and 36.89% as compared to 42.65% and 57.35% in the controls. OR for I and D was 2.3.

Significant differences were observed in the genotypes and alleles frequencies of *ACE* gene on comparing senile cataract cases with healthy control group \[[Table 2](#T2){ref-type="table"} for details\].

###### 

Genotype and allele frequencies of angiotensin-converting enzyme and *CYP46A1* genes in cataract cases and healthy controls

![](OJO-10-21-g004)

### *CYP46A1* polymorphism analysis {#sec3-4}

The *CYP46A1* gene CT, CC, TT genotypes frequencies were 48.54%, 8.73%, 42.71% in cases and 28.43%, 3.92%, 67.64% in healthy controls, respectively. OR for CT genotype was 2.375 (*P* = 0.912), for CC genotype was 2.346 (*P* = 0.157), and for TT genotype was 0.357 (*P* = 0.0003). The frequencies of C and T alleles were 33.01% and 66.99% in cases as compared to 18.14% and 81.86% in the controls. OR for C was 2.224 and for T allele was 0.449 (*P* \< 0.001).

Significant association was found between *CYP46A1* genes polymorphism with senile cataract where CT, TT genotypes and C, T allele were found to increase the risk of senile cataract whereas CC genotype and C allele conferred a low risk for the same \[[Table 2](#T2){ref-type="table"} for details\].

Discussion {#sec1-4}
==========

Age-related cataracts are responsible for 48% of world blindness, which represents about 18 million people, according to the WHO.\[[@ref15]\] Previously, many studies investigated the association between genetic polymorphisms and cataract. According to our data, we have found a significant difference in weight (*P* \< 0.001), intraocular pressure (*P* \< 0.001), diastolic blood pressure (*P* = 0.016), serum bilirubin (*P* \< 0.001), hemoglobin (*P* \< 0.001), total leukocytes count (*P* \< 0.001), eosinophils (*P* \< 0.001), platelet count (*P* = 0.009) between cases and control.

Angiotensin-converting enzyme polymorphism {#sec2-8}
------------------------------------------

Numerous studies have previously investigated *ACE* I/D polymorphism as a potential risk factor for many eye-related diseases such as retinopathy and glaucoma.\[[@ref16][@ref17]\] In our study, on *ACE* gene polymorphism, we observed no significant relationship between *ACE* ID genotype and cataract (*P* = 0.732). We found that the frequency of occurrence of II genotypes was higher in our senile cataract cases (31.06%) as compared to controls (11.76%), whereas the frequency of DD genotype was lower in cases (4.85%) as compared to controls (26.47%), respectively. On studying the allele frequencies between cases and controls, we found that the frequency of carrying I allele was significantly higher in cases (63.11%, *P* \< 0.001) as compared to controls (42.65%) suggesting I allele to be a positive risk factor for senile cataract. On the other hand, frequency of D allele was significantly lower in cases (36.89%, *P* \< 0.001) as compared to controls (57.35%) suggesting D allele to be a negative risk factor for senile cataract. The above results are shown in [Table 2](#T2){ref-type="table"}.

### *CYP46A1* polymorphism {#sec3-5}

*CYP46A1* gene was initially identified as a cholesterol-metabolizing enzyme in the brain. The TT genotype in intron 2 of *CYP46A1*, designated as the rs754203 SNP, has been identified as a risk factor for Alzheimer disease,\[[@ref6][@ref7][@ref8]\] and more recently, for POAG.\[[@ref18]\]*CYP46A1* and its metabolic product 24S-hydroxycholesterol are specific for the neural retina, and especially for retinal ganglion cells.\[[@ref9][@ref10]\] We have observed significant association between *CYP46A1* gene polymorphism and cataract. According to our data, the frequency of CT genotype and C allele was significantly higher in cases than control (*P* = 0.003, *P* \< 0.001). We have found that the frequency of TT genotype and T allele was significantly lower in cases as compared to the control (*P* \< 0.001). In our study, we found that the frequency of CT genotype in senile cataract cases was 48.54% which was similar to the frequency of CT genotype in French cataract cases 49.2%.\[[@ref19]\] The frequency of CC genotype in senile cataract cases in our study was 8.73% which was slightly higher than French cataract cases (2.5%).\[[@ref19]\] The frequencies of TT genotype in our population (42.71%) were found to be lower as compared to the Australian population with cataract (47.8%).\[[@ref18]\] Our results show that CC genotype was not significant between cases and control (*P* = 0.157).

Conclusion {#sec1-5}
==========

Findings of this study suggest that *ACE* and *CYP46A1* genes polymorphism can be a predictive marker for early identification of population at risk of cataract. This potential role of *ACE* and *CYP46A1* genes polymorphism as a marker of susceptibility to senile cataract needs further validation in studies involving larger number of patients from different regions.
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